Another study demonstrated that higher expression of AFAP1‐AS1 was significantly correlated with larger tumour size, lymph node metastasis, higher tumour–node–metastasis (TNM) stage and worse overall survival in patients with NSCLC. This evidence concerns the gene AFAP1 and non-small cell lung carcinoma.